Secondary Outcome(s)
|
Change From Baseline in Bath Ankylosing Spondylitis Functional Index (BASFI) at Week 52
[Time Frame: Baseline, Week 52]
|
Change From Baseline in Duration of Morning Stiffness at Week 52
[Time Frame: Baseline, Week 52]
|
Percentage of Participants With Serious Adverse Events (SAEs) or Adverse Events (AEs)
[Time Frame: Baseline up to Week 52]
|
Change From Baseline in Lateral Lumbar Flexion at Week 52
[Time Frame: Baseline, Week 52]
|
Percentage of Participants With Presence of Enthesitis
[Time Frame: Baseline, Week 2, 6, 12, 26, 38, 52]
|
Percentage of Participants With Serious Adverse Events (SAEs) or Adverse Events (AEs) by Co-morbidity
[Time Frame: Baseline up to Week 52]
|
Change From Baseline in Number of Affected Joints by Peripheral Arthritis at Week 52
[Time Frame: Baseline, Week 52]
|
Change From Baseline in Physician Global Assessment (PGA) of Disease Activity at Week 52
[Time Frame: Baseline, Week 52]
|
Change From Baseline in Occiput-to-Wall Distance at Week 52
[Time Frame: Baseline, Week 52]
|
Healthcare Resource Utilization
[Time Frame: Baseline, Week 26, 52]
|
Percentage of Participants With Assessment in Ankylosing Spondylitis 40 (ASAS-40) Response
[Time Frame: Week 12, 26, 38, 52]
|
Percentage of Participants With Discontinuation of Treatment Due to Adverse Events
[Time Frame: Baseline up to Week 52]
|
Percentage of Participants With Presence of Peripheral Arthritis
[Time Frame: Baseline, Week 2, 6, 12, 26, 38, 52]
|
Percentage of Participants With Significant Reduction of Morning Stiffness
[Time Frame: Week 2, 6, 12, 26, 38, 52]
|
Euro Quality of Life (EQ--5D)- Visual Analog Scale (VAS)
[Time Frame: Baseline, Week 26, 52]
|
Percentage of Participants With Assessment in Ankylosing Spondylitis 20 (ASAS-20) Response
[Time Frame: Week 12, 26, 38, 52]
|
Change From Baseline in Number of Affected Body Parts by Enthesitis at Week 52
[Time Frame: Baseline, Week 52]
|
Change From Baseline in Patient's Global Assessment (PtGA) of Pain at Week 52
[Time Frame: Baseline, Week 52]
|
Change From Baseline in Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) at Week 52
[Time Frame: Baseline, Week 52]
|
Euro Quality of Life-5 Dimensions (EQ-5D) Time Trade Off (TTO)
[Time Frame: Baseline, Week 26, 52]
|
Change From Baseline in C-Reactive Protein (CRP) at Week 52
[Time Frame: Baseline, Week 52]
|
Change From Baseline in Erythrocyte Sedimentation Rate (ESR) at Week 52
[Time Frame: Baseline, Week 52]
|
Change From Baseline in Patient Global Assessment (PtGA) of Disease Activity at Week 52
[Time Frame: Baseline, Week 52]
|
Duration of Healthcare Resources Utilization
[Time Frame: Baseline, Week 26, 52]
|
Percentage of Participants With Prior or Concomitant Medication Use for Treatment of Ankylosing Spondylitis
[Time Frame: Baseline up to Week 52]
|
Work Productivity and Activity Impairment - Special Health Problems (WPAI:SHP)
[Time Frame: Baseline, Week 26, 52]
|